Seroquel Sales Aid Cited By FDA For Minimizing Diabetes Risk
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca’s material “undermines” class hyperglycemia and diabetes warnings from the atypical antipsychotic’s label, FDA says.